Coverage
-
July 09, 2021
The Ninth Circuit on Friday affirmed the dismissal of a whistleblower's nearly 12-year-old allegations that Merck & Co. and other drugmakers violated the False Claims Act by offering doctors kickbacks to prescribe their blood-thinning drugs, finding that the former sales employee's allegations were "purely speculative."
1 other articles on this case.
View all »